ARGX · Argenx SE · Webcasts, Transcripts & Audio
$960.04
-21.29 (-2.17%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$60.37B
Shares
62.89M
Volume · Nov 13
226.16K
Avg daily vol (3M)
365.92K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Argenx SE Webcasts
Earnings calls, investor updates, investor days and conferences for Argenx SE (ARGX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-17
Argenx SE (ARGX) November 17, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-10
Argenx SE (ARGX) November 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-10-22
Argenx SE (ARGX) Q3 2026 Earnings Call Transcript
Confident tone
VivGuard growth and expansion
P_assertus Prubart in MMN
FB102 celiac and pipeline potential
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-14
Argenx SE (ARGX) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-08
Argenx SE (ARGX) September 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-01
Argenx SE (ARGX) September 1, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-01
Argenx SE (ARGX) September 1, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-23
Argenx SE (ARGX) Q2 2026 Earnings Call Transcript
Confident tone
CIDP market expansion
Myositis readout and rheumatology entry
Pipeline and next-gen FCRN
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Argenx SE (ARGX) June 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Argenx SE (ARGX) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Argenx SE (ARGX) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Argenx SE (ARGX) Q1 2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Argenx SE (ARGX) Q4 2025 Earnings Call Transcript
Confident tone
VYVGART franchise growth and patient reach
MG label expansion (seronegative and ocular)
CIDP momentum and label update
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Argenx SE (ARGX) Q3 2025 Earnings Call Transcript
Confident tone
VYVGART commercial momentum
Upcoming 2026 registrational readouts
Pipeline expansion and Phase III assets
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Date not confirmed
Argenx SE (ARGX) Q2 2025 Earnings Call Transcript
Confident tone
VYVGART commercial performance
CIDP launch progress
Indication breadth - myositis, Sjogren's, TED
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Argenx SE (ARGX) Q1 2025 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Date not confirmed
Argenx SE (ARGX) Q4 2024 Earnings Call Transcript
Confident tone
VYVGART commercial momentum and launch execution
Pipeline expansion and innovation engine
Empasiprubart (C2 inhibitor) registrational strategy
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Argenx SE (ARGX) Q3 2024 Earnings Call Transcript
Confident tone
CIDP launch (VYVGART Hytrulo)
VYVGART commercial momentum (gMG)
Pipeline and pipeline expansion
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Argenx SE (ARGX) Q2 2024 Earnings Call Transcript
Confident tone
CIDP launch
Vision 2030 and long-term growth ambitions
Clinical trial execution and inherent risks
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Argenx SE (ARGX) Q1 2024 Earnings Call Transcript
Confident tone
VYVGART commercial growth
Pre-filled syringe and label expansion
Clinical pipeline expansion
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Argenx SE (ARGX) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Argenx SE (ARGX) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Argenx SE (ARGX) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Argenx SE (ARGX) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Argenx SE (ARGX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q2
2022-06-30
Date not confirmed
Argenx SE (ARGX) Q2 2022 Earnings Call Transcript
Revenue
$96.00M
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Date not confirmed
Argenx SE (ARGX) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Date not confirmed
Argenx SE (ARGX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Date not confirmed
Argenx SE (ARGX) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Date not confirmed
Argenx SE (ARGX) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Date not confirmed
Argenx SE (ARGX) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Date not confirmed
Argenx SE (ARGX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q2
2020-06-30
Date not confirmed
Argenx SE (ARGX) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Date not confirmed
Argenx SE (ARGX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–34 of 34 webcasts
Key facts
CIK
1697862
CUSIP
04016X101
13F (30d)
461 filings
408 filers
Visit website
Investor relations